SCHEMBL470874

SCHEMBL470874

CCN1CCNCC1c1cccnc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 6/20 0.47
CHRNA4 P43681 6/20 0.47
CHRNA7 P36544 5/20 0.47
ALDH1A1 P00352 3/20 0.47
CHRNB4 P30926 2/20 0.47
CHRNA3 P32297 2/20 0.47
CHRNA2 Q15822 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
LMNA P02545 1/20 0.47
HTR3E A5X5Y0 1/20 0.47
PSIP1 O75475 1/20 0.47
TRPA1 O75762 1/20 0.47
HTR3B O95264 1/20 0.47
CHRNA1 P02708 1/20 0.47
CHRNG P07510 1/20 0.47
MAPT P10636 1/20 0.47
CHRNB1 P11230 1/20 0.47
CYP2A6 P11509 1/20 0.47
PTGS1 P23219 1/20 0.47
CHRNA5 P30532 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27569730 0.84 CHRNA7 (0.45) CHRNB2CHRNA4CHRNA7ALDH1A1CHRNB4
SCHEMBL14833617 0.83 ALDH1A1 (0.43) CHRNB2CHRNA4CHRNA7ALDH1A1CHRNB4
SCHEMBL410563 0.82 P2RX7 (0.43) CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3
SCHEMBL470870 0.82 P2RX7 (0.43) CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3
SCHEMBL15217034 0.81 CHRNB2 (0.61) CHRNB2CHRNA4CHRNA7ALDH1A1CHRNB4
Hydrochloric Acid SCHEMBL28787386 0.80 CHRNB2 (0.60) CHRNB2CHRNA4CHRNA7ALDH1A1CHRNB4
SCHEMBL157171 0.78 ALDH1A1 (0.66) CHRNB2CHRNA4CHRNA7ALDH1A1CHRNB4
SCHEMBL29606745 0.78 ALDH1A1 (0.66) CHRNB2CHRNA4CHRNA7ALDH1A1CHRNB4
SCHEMBL29683697 0.78 ALDH1A1 (0.66) CHRNB2CHRNA4CHRNA7ALDH1A1CHRNB4
SCHEMBL28497766 0.78 ALDH1A1 (0.66) CHRNB2CHRNA4CHRNA7ALDH1A1CHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2615089-B1 Pyrazoloquinoline compounds ASTELLAS PHARMA INC (JP) 2016-04-27 EP disclosed
US-8822448-B2 Pyrazoloquinoline compound ASTELLAS PHARMA INC. (JP) 2014-09-02 US disclosed
US-8822448-B2 Pyrazoloquinoline compound ASTELLAS PHARMA INC. (JP) 2014-09-02 US disclosed
US-20130225553-A1 PYRAZOLOQUINOLINE COMPOUND ASTELLAS PHARMA INC. (JP) 2013-08-29 US disclosed
US-20130225553-A1 PYRAZOLOQUINOLINE COMPOUND ASTELLAS PHARMA INC. (JP) 2013-08-29 US disclosed
WO-2012033144-A1 PYRAZOLOQUINOLINE COMPOUND アステラス製薬株式会社 (JP) 2012-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225553-A1 PYRAZOLOQUINOLINE COMPOUND PDE9A, PDE5A, PDE2A CHRNB2 3579/4885CHRNA4 2911/4885CHRNA7 2499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.